CELLDEX THERAPEUTICS INC NEW's ticker is and the CUSIP is 15117B902. A total of 5 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $2,304,153 | +433.0% | 54,900 | +403.7% | 0.00% | – |
Q4 2023 | $432,294 | -63.6% | 10,900 | -67.0% | 0.00% | – |
Q1 2023 | $1,187,340 | +80.0% | 33,000 | +123.0% | 0.00% | – |
Q4 2022 | $659,636 | +40.6% | 14,800 | -11.4% | 0.00% | – |
Q3 2022 | $469,000 | -96.4% | 16,700 | -96.5% | 0.00% | -100.0% |
Q2 2022 | $12,925,000 | – | 479,400 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 11,200 | $380,016 | 0.00% |
SIMPLEX TRADING, LLC | 6,400 | $217 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |